FXR (NR1H4) MODULATING COMPOUNDS

The present disclosure relates generally to compounds that bind to FXR and act as agonists of FXR. The disclosure further relates to the use of the compounds for the preparation of a medicament for the treatment of diseases and/or conditions through binding of said nuclear receptor by said compounds...

Full description

Saved in:
Bibliographic Details
Main Authors KROPF, Jeffrey E, HORSTMAN, Elizabeth M, WATKINS, William J, KAPLAN, Joshua A, FRICK, Morin Mae, CURRIE, Kevin S, BLOMGREN, Peter A
Format Patent
LanguageEnglish
French
German
Published 01.05.2024
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present disclosure relates generally to compounds that bind to FXR and act as agonists of FXR. The disclosure further relates to the use of the compounds for the preparation of a medicament for the treatment of diseases and/or conditions through binding of said nuclear receptor by said compounds and to a process for the synthesis of said compounds.
Bibliography:Application Number: EP20230215648